As of Jan 17
| -0.26 / -12.44%|
The 2 analysts offering 12-month price forecasts for Biocept Inc have a median target of 1.58, with a high estimate of 1.60 and a low estimate of 1.55. The median estimate represents a -13.93% decrease from the last price of 1.83.
The current consensus among 2 polled investment analysts is to Buy stock in Biocept Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.